Evidence map›Paper›PMID 14722210›Full record

ArticleAnnals of the rheumatic diseases2004

Dual effects of 17beta-oestradiol on interleukin 1beta-induced proteoglycan degradation in chondrocytes.

P Richette, M F Dumontier, M François, L Tsagris, C Korwin-Zmijowska, F Rannou, M T Corvol

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Annals of the rheumatic diseases, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Review
  3. Sex Difference in OA: Should We Blame Estrogen?European journal of rheumatology · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Menopause and Rheumatic Disease.Rheumatic diseases clinics of North America · 2017
    Review
  8. Article
  9. Article
  10. Impact of treatments for osteoporosis on cartilage biomarkers in humans.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2012
    Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

P RichetteUMR-S U530 INSERM-Université Paris 5, UFR Biomédicale, 45 rue des Saints Pères, 75270 Paris, Cedex 06, France. pascal.richette@lrb.ap-hop-paris.fr
M F Dumontier
M François
L Tsagris
C Korwin-Zmijowska
F Rannou
M T Corvol
Université Paris Cité · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo determine whether 17beta-oestradiol (E2) modulates interleukin (IL) 1beta-induced proteoglycan degradation in chondrocytes, and to analyse the part played by metalloproteinases (MMPs) in this process.

methodsPrimary cultured rabbit articular chondrocytes were prepared and treated with 10 ng/ml IL1beta combined or not with 0.1-10 nM E2. Neosynthesised proteoglycans (PGs) were evaluated after incorporation of [(35)SO(4)]sulphate and further analysed after chromatography on a Sepharose 2B column. Chondrocyte mRNA levels of aggrecan, MMP-1, -3, -13, and tissue inhibitor of metalloproteinase-1 (TIMP-1) were studied by northern blot. MMP-1 activity was measured by zymography. MMP-1 gene transcription was studied by transient transfection of chondrocytes with an MMP-1-luciferase construct.

resultsE2 modulated the IL1beta-induced total sulphated PGs in rabbit articular chondrocytes, which decreased as the E2 concentration was increased. At a low concentration (0.1 nmol/l) E2 counteracts the IL1beta-induced decrease in sulphated PG, while at high concentration (10 nmol/l) E2 enhances the IL1beta effects. A biphasic E2 effect was also observed on IL1beta-induced disaggregation of PG, 53-58 kDa gelatinolytic activity, and MMP-1, -3, and -13 mRNA levels. In contrast, E2 did not modify the level of aggrecan mRNA and had no effect on TIMP-1 mRNA expression. Finally, simultaneous addition of IL1beta and E2 (0.1-10 nmol/l) did not modify IL1beta-induced MMP-1-luciferase activity, suggesting that E2 effects probably occur at the post-transcriptional level of MMP gene expression.

conclusionOestrogen concentration may have an inverse effect on IL1beta stimulated proteoglycan degradation and MMP production by chondrocytes.

Indexed as

Extracellular Matrix ProteinsAggrecansAnimalsChondrocytesCollagenasesDepression, ChemicalEstradiolGene ExpressionInterleukin-1Lectins, C-TypeMatrix Metalloproteinase 1Matrix Metalloproteinase 13Matrix Metalloproteinase 3OsteoarthritisProteoglycansRabbitsAggrecansCollagenasesEstradiolExtracellular Matrix ProteinsInterleukin-1Lectins, C-TypeMatrix Metalloproteinase 1Matrix Metalloproteinase 13Matrix Metalloproteinase 3ProteoglycansRNA, MessengerTissue Inhibitor of Metalloproteinase-1

Identifiers

PMID14722210
PMCPMC1754890
OpenAlexW2073779909

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.